SIRT1 and Alzheimer disease: Still in the AD group, a significant reduction of ROS was observed when the cells were previously treated with sirtinol and subsequently stimulated with H2O2, when compared with the group that received only H2O2, indicating that SIRT1 is an active antioxidant pathway.